Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-004650-93-NL
EUCTR2007-004650-93-NL
Active, Not Recruiting
N/A

The effect of Botulinum toxin A injections for overactive bladder on detrusor contractility - Botulinum toxin A and detrusor contractility

niversity Medical Center Groningen0 sitesAugust 29, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsBOTOX ®

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Medical Center Groningen
Status
Active, Not Recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 29, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with an overactive bladder, planned for Botulinum toxin A injection, will be included in this study.
  • •Male and female patients 20 – 70 years of age
  • •Symptoms of overactive bladder for more than 6 months
  • •Overactive bladder is defined as urgency and frequency with or without incontinence.
  • •Micturition frequency \> 7 times/day
  • •Incontinence episodes \> 6/week
  • •Detrusor overactivity on urodynamic investigation (consisting of decreased detrusor compliance, early detrusor contractions)
  • •Informed consent is obtained
  • •Patients are capable of filling out a micturition diary and Quality of Life\-questionnaire
  • •Are the trial subjects under 18? no

Exclusion Criteria

  • •Treatment with Botulinum toxin A in the last 9 months
  • •Treatment with anticholinergic drugs during the last 2 weeks
  • •Active or repeated urinary tract infection
  • •Peripheral neuropathy (i.e. Diabetic neuropathy)
  • •Having an indwelling catheter
  • •Malignancy in the area of the pelvis
  • •Pelvic surgery in the last 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 4
The effect of Botulinum toxin A injections for overactive bladder on detrusor contractilityoveractive bladderurine incontinence10046590
NL-OMON31265niversitair Medisch Centrum Groningen10
Completed
Phase 2
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42
IRCT20190129042540N1Rafsanjan University of Medical Sciences50
Active, Not Recruiting
N/A
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Recruiting
N/A
Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticitySpinal Cord Injury and Stroke
NL-OMON26235Sint Maartenskliniek Research10